ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

HCM Hutchmed (china) Limited

283.00
-7.00 (-2.41%)
Jun 07 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Hutchmed (china) Limited HCM London Ordinary Share
  Price Change Price Change % Share Price Last Trade
-7.00 -2.41% 283.00 10:35:04
Open Price Low Price High Price Close Price Previous Close
285.00 279.00 285.00 283.00 290.00
more quote information »
Industry Sector
PHARMACEUTICALS & BIOTECHNOLOGY

Recent News

Date Time Source Heading
6/07/202412:13ALNCNewsIN BRIEF: Hutchmed (China) begins trial of menin inhibitor..
6/07/202401:00UK RNSHutchmed (China) Limited HUTCHMED Initiates Phase I Trial of..
6/03/202401:00UK RNSHutchmed (China) Limited Nature Medicine Publish Phase III..
5/31/202403:30UK RNSHutchmed (China) Limited Total Voting Rights
5/24/202401:00UK RNSHutchmed (China) Limited HUTCHMED Presentations at 2024 ASCO..
5/17/202411:58ALNCNewsIN BRIEF: Hutchmed China Simon To leaves role, succeeded by..
5/17/202409:00UK RNSHutchmed (China) Limited Retirement of Chairman and new..
5/17/202401:00UK RNSHutchmed (China) Limited HUTCHMED Data to be Presented at..
5/14/202408:33ALNCNewsHutchmed announces trials of HMPL-306 and Surufatinib cancer..
5/14/202401:00UK RNSHutchmed (China) Limited HUTCHMED Initiates Registrational..
5/14/202401:00UK RNSHutchmed (China) Limited HUTCHMED Initiates Phase II/III..
5/10/202407:00UK RNSHutchmed (China) Limited Result of AGM
5/08/202403:30UK RNSHutchmed (China) Limited Directorate Change
4/26/202410:09ALNCNewsHutchmed notes CHMP's positive opinion for fruiquintinib..
4/26/202407:30UK RNSHutchmed (China) Limited Positive CHMP Opinion for..
4/22/202403:30UK RNSHutchmed (China) Limited Vesting of Awards Under the LTIP
4/08/202403:30UK RNSHutchmed (China) Limited 2023 Annual Report and Notice of..
4/05/202403:30UK RNSHutchmed (China) Limited Data to be Presented at AACR..
4/02/202404:32ALNCNewsHutchmed endometrial cancer treatment application accepted..
4/02/202401:00UK RNSHutchmed (China) Limited HUTCHMED and Innovent Announce NDA..
3/28/202406:08ALNCNewsHutchmed lung cancer treatment accepted for review in China
3/28/202402:00UK RNSHutchmed (China) Limited Savolitinib sNDA Accepted in China
3/22/202405:09ALNCNewsHutchmed begins registration stage for sovleplenib phase 2/3..
3/22/202402:16ALNCNews*CORRECT: Hutchmed China initiates registration for phase 3..
3/22/202402:00UK RNSHutchmed (China) Limited Initiation of Registration Stage of..
3/14/202404:00UK RNSHutchmed (China) Limited LTIP and Share Option Scheme
3/05/202402:30UK RNSHutchmed (China) Limited Vesting of awards under the LTIP
2/28/202411:31ALNCNewsEARNINGS: Hutchmed revenue surges, Craven House's loss..
2/28/202406:45UK RNSHutchmed (China) Limited Publication of Form 20-F
2/28/202405:30UK RNSHutchmed (China) Limited 2023 Full Year Results and Business..
2/07/202403:50ALNCNewsHutchmed hails fruquintinib trial results for gastric cancer..
2/07/202401:00UK RNSHutchmed (China) Limited Presentation of Phase III Data on..
2/02/202403:52ALNCNewsHutchmed says Inmagene exercises option to licence drug..
2/02/202402:37UK RNSHutchmed (China) Limited Inmagene Exercises Option for Two..
2/01/202402:30UK RNSHutchmed (China) Limited HUTCHMED to Announce 2023 Final..
1/30/202403:20ALNCNewsHutchmed celebrates cancer drug approval in hometown of Hong..
1/30/202401:12UK RNSHutchmed (China) Limited HUTCHMED Receives Marketing..
1/11/202404:17ALNCNewsTOP NEWS: Hutchmed Sovleplenib accepted for review by China..
1/11/202401:00RNSNONHutchmed (China) Limited Sovleplenib NDA Granted Priority..
12/29/202302:30UKREGHutchmed (China) Limited Blocklisting Six Monthly Return
12/29/202302:30UKREGHutchmed (China) Limited Total Voting Rights
12/21/202305:36ALNCNewsIN BRIEF: Hutchmed China renews deals with "substantial"..
12/21/202304:00UKREGHutchmed (China) Limited Overseas Regulatory Announcement
12/13/202307:56ALNCNewsHutchmed completes enrolment for fruquintinib trial
12/13/202301:00RNSNONHutchmed (China) Limited Completed Enrollment of Phase..
12/07/202304:04UKREGHutchmed (China) Limited Overseas Regulatory Announcement
12/01/202301:00RNSNONHutchmed (China) Limited Clinical Data to be Presented at..
11/30/202302:30UKREGHutchmed (China) Limited Total Voting Rights
11/09/202306:16ALNCNewsHutchmed hails Takeda's fruquintinib approval from US for..
11/09/202301:00UKREGHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM)..

Your Recent History

Delayed Upgrade Clock